title: A feasibility study on maintenance of docetaxel after paclitaxel-carboplatin chemotherapy in patients with advanced ovarian cancer.
abstract: OBJECTIVE
  To test the concept of taxane sequencing, this feasibility trial evaluated maintenance of docetaxel after paclitaxel and carboplatin combination chemotherapy in patients with stage IC-IV ovarian cancer.
  
  
  METHODS
  All patients received debulking surgery followed by paclitaxel and carboplatin chemotherapy. Attainment of clinically defined complete or partial response was confirmed by image scanning. Maintenance of docetaxel started at an initial dose of 70 mg/m(2) every 4 weeks for 6 cycles and was extended to 10 cycles unless disease progression and/or recurrence during the protocol therapy or unacceptable toxicities were seen.
  
  
  RESULTS
  Stage subsets in 20 eligible patients were as follows: IIIB, 2 patients (10%); IIIC, 13 patients (65%); IV, 5 patients (25%). Neutropenia was common (40% with grade 3 or 4) and was most frequent during first or second cycle although the disabling peripheral neuropathy was not observed. Twelve patients completed protocol therapy (6≤cycles), while 8 patients failed to complete 6-cycle chemotherapy, because of progressive disease (5 patients) or grade 4 toxicities (3 patients). Median PFS was 20 months and 3-year PFS rate was 12%. Median overall survival was 39 months and 3-year OS rate was 69%.
  
  
  CONCLUSIONS
  Six cycles of single-agent docetaxel maintenance chemotherapy is feasible and generally tolerable to women with advanced ovarian cancer who attained a clinically defined response to initial paclitaxel and carboplatin based chemotherapy.
authors: Department of Obstetrics and Gynecology, Jikei Daisan Hospital, Tokyo, Japan.
authors: Seiji
authors: S
authors: Isonishi
authors: Masaaki
authors: M
authors: Suzuki
authors: Hiroaki
authors: H
authors: Nagano
authors: Koichiro
authors: K
authors: Takagi
authors: Masahito
authors: M
authors: Shimauchi
authors: Masakiyo
authors: M
authors: Kawabata
authors: Kazuhiko
authors: K
authors: Ochiai
keywords: Chemotherapy; Docetaxel; Maintenance; Ovarian cancer
references: Hum Cell. 2010 Nov;23(4):156-63
references: 21166887
references: J Clin Oncol. 2003 Jul 1;21(13):2460-5
references: 12829663
references: J Clin Oncol. 2004 Jul 1;22(13):2635-42
references: 15226331
references: J Natl Cancer Inst. 2000 May 3;92(9):699-708
references: 10793106
references: N Engl J Med. 2011 Dec 29;365(26):2473-83
references: 22204724
references: N Engl J Med. 2011 Dec 29;365(26):2484-96
references: 22204725
references: J Natl Cancer Inst. 2006 Aug 2;98(15):1036-45
references: 16882940
references: J Clin Oncol. 1999 Jul;17(7):2069-80
references: 10561260
references: N Engl J Med. 1996 Jan 4;334(1):1-6
references: 7494563